Senexin C

Modify Date: 2024-01-19 14:06:23

Senexin C Structure
Senexin C structure
Common Name Senexin C
CAS Number 2375554-02-0 Molecular Weight 449.558
Density N/A Boiling Point N/A
Molecular Formula C28H27N5O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Senexin C


Senexin C is a novel potent, selective and orally bioavailable CDK8/19 inhibitor with Kd of 1.4 and 2.9 nM for CDK8/CycC and CDK19/CycC, respectively.Senexin C inhibits CDK8/CycC with IC50 of 3.6 nM, shows high selectivity against other HDAC isoforms.Senexin C is more metabolically stable and provides a more sustained inhibition of CDK8/19-dependent cellular gene expression when compared with the prototype inhibitor Senexin B.Senexin C inhibits MV4-11 leukemia growth in a systemic in vivo model with good tolerability.

 Names

Name Senexin C

 Senexin C Biological Activity

Description Senexin C is a novel potent, selective and orally bioavailable CDK8/19 inhibitor with Kd of 1.4 and 2.9 nM for CDK8/CycC and CDK19/CycC, respectively.Senexin C inhibits CDK8/CycC with IC50 of 3.6 nM, shows high selectivity against other HDAC isoforms.Senexin C is more metabolically stable and provides a more sustained inhibition of CDK8/19-dependent cellular gene expression when compared with the prototype inhibitor Senexin B.Senexin C inhibits MV4-11 leukemia growth in a systemic in vivo model with good tolerability.
References 1. Li Zhang, et al. J. Med. Chem. 2022

 Chemical & Physical Properties

Molecular Formula C28H27N5O
Molecular Weight 449.558